Skip to main content

Table 1 Anthropometric measures of participants during HPL and LPL krill and control oil interventions

From: Supplementation of krill oil with high phospholipid content increases sum of EPA and DHA in erythrocytes compared with low phospholipid krill oil

Parameter

Treatment

Baseline

Endpoint

Change (Difference)

Body Weight (Kg)

HPL Krill oil

67.53 ± 2.75

67.96 ± 2.63

0.43 ± 0.37

LPL krill oil

67.99 ± 2.77

67.74 ± 2.73

−0.25 ± 0.22a

Control

67.56 ± 2.46

67.73 ± 2.44

0.18 ± 0.22

BMI (kg/m2)

HPL Krill oil

23.62 ± 0.68

23.75 ± 0.63

0.13 ± 0.15

LPL krill oil

23.79 ± 0.71

23.69 ± 0.71

−0.10 ± 0.08

Control

23.61 ± 0.63

23.67 ± 0.62

0.06 ± 0.09

Waist (cm)

HPL Krill oil

77.95 ± 1.98

78.20 ± 1.93

0.25 ± 0.27

LPL krill oil

78.25 ± 2.03

77.81 ± 2.05

−0.43 ± 0.37

Control

78.05 ± 1.80

78.14 ± 1.78

0.09 ± 0.15

Hip (cm)

HPL Krill oil

92.04 ± 1.19

92.45 ± 1.14

0.41 ± 0.34

LPL krill oil

92.69 ± 1.22

92.92 ± 1.20

0.23 ± 0.28

Control

92.70 ± 1.10

92.71 ± 1.07

0.01 ± 0.12

Waist/Hip ratio

HPL Krill oil

0.85 ± 0.02

0.84 ± 0.02

0.00 ± 0.00

LPL krill oil

0.84 ± 0.02

0.84 ± 0.02

−0.01 ± 0.00

Control

0.84 ± 0.02

0.84 ± 0.01

0.00 ± 0.00

Systolic BP (mmHg)

HPL Krill oil

106.80 ± 2.63

108.14 ± 2.00a

1.35 ± 1.39

LPL krill oil

106.35 ± 2.45

103.97 ± 2.73

−2.38 ± 1.56

Control

107.99 ± 2.13

105.89 ± 2.36

−2.11 ± 1.15

Diastolic BP (mmHg)

HPL Krill oil

71.45 ± 1.69

72.53 ± 1.32

1.09 ± 0.88

LPL krill oil

71.17 ± 1.96

70.5 ± 1.86

−0.67 ± 1.34

Control

72.26 ± 1.68

71.05 ± 1.84

−1.21 ± 1.05

Heart rate (Beats/min)

HPL Krill oil

71.35 ± 2.43

70.25 ± 1.72

−1.10 ± 2.07

LPL krill oil

73.25 ± 2.23

69.1 ± 1.74

−4.15 ± 1.70

Control

71.55 ± 1.66

71.80 ± 1.65

0.25 ± 1.09

  1. Values are expressed as Mean ± SEM. n = 20. adenotes significance compared with LPL krill oil intervention